NCT02481310 2022-02-21
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
Northwestern University
Phase 1/2 Unknown
Northwestern University
PETHEMA Foundation
Erasmus Medical Center
Peking Union Medical College Hospital
Dutch Childhood Oncology Group
West China Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Japan Adult Leukemia Study Group